JP2012152636A - 組織へ流体を供与する装置、システムおよび関連方法 - Google Patents

組織へ流体を供与する装置、システムおよび関連方法 Download PDF

Info

Publication number: JP2012152636A
Authority: JP; Japan
Prior art keywords: fluid; shaft; orifice; tip; fluid delivery
Prior art date: 2005-12-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

JP2012118761A

Other languages

English (en)

Japanese (ja)

Inventor

Vincent G Copa

ジー．コパ，ビンセント

Suranjan Roychowdhury

ロイチョウドゥリー，スランジャン

Justin M Crank

エム．クランク，ジャスティン

Sidney F Hauschild

エフ．ハウシルト，シドニー

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AMS Research LLC

Original Assignee

AMS Research LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-28

Filing date

2012-05-24

Publication date

2012-08-16

2012-05-24 Application filed by AMS Research LLC filed Critical AMS Research LLC

2012-08-16 Publication of JP2012152636A publication Critical patent/JP2012152636A/ja

Status Withdrawn legal-status Critical Current

Links

239000012530 fluid Substances 0.000 title claims abstract description 773
238000000034 method Methods 0.000 title claims abstract description 54
210000003932 urinary bladder Anatomy 0.000 claims abstract description 143
210000001519 tissue Anatomy 0.000 claims abstract description 130
230000003287 optical effect Effects 0.000 claims abstract description 56
210000003708 urethra Anatomy 0.000 claims abstract description 49
210000002307 prostate Anatomy 0.000 claims abstract description 21
210000001635 urinary tract Anatomy 0.000 claims description 51
238000004891 communication Methods 0.000 claims description 39
210000005068 bladder tissue Anatomy 0.000 claims description 9
210000002700 urine Anatomy 0.000 claims description 7
210000005084 renal tissue Anatomy 0.000 claims 1
230000007246 mechanism Effects 0.000 abstract description 87
210000003739 neck Anatomy 0.000 abstract description 55
210000000626 ureter Anatomy 0.000 abstract description 23
210000003734 kidney Anatomy 0.000 abstract description 21
239000011799 hole material Substances 0.000 description 57
238000002347 injection Methods 0.000 description 32
239000007924 injection Substances 0.000 description 32
230000004913 activation Effects 0.000 description 21
239000000463 material Substances 0.000 description 20
239000003814 drug Substances 0.000 description 19
238000001802 infusion Methods 0.000 description 17
238000011282 treatment Methods 0.000 description 14
229940079593 drug Drugs 0.000 description 13
229910052751 metal Inorganic materials 0.000 description 13
229920000642 polymer Polymers 0.000 description 13
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
239000002184 metal Substances 0.000 description 12
239000013307 optical fiber Substances 0.000 description 12
230000001225 therapeutic effect Effects 0.000 description 10
238000013461 design Methods 0.000 description 9
239000002861 polymer material Substances 0.000 description 7
229910002092 carbon dioxide Inorganic materials 0.000 description 6
239000001569 carbon dioxide Substances 0.000 description 6
238000009434 installation Methods 0.000 description 5
239000012528 membrane Substances 0.000 description 5
239000000126 substance Substances 0.000 description 5
229940124597 therapeutic agent Drugs 0.000 description 5
229920001971 elastomer Polymers 0.000 description 4
-1 ether ketone Chemical class 0.000 description 4
239000000835 fiber Substances 0.000 description 4
229920005570 flexible polymer Polymers 0.000 description 4
229920000126 latex Polymers 0.000 description 4
239000004816 latex Substances 0.000 description 4
HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 4
229910001000 nickel titanium Inorganic materials 0.000 description 4
229920001296 polysiloxane Polymers 0.000 description 4
229920002635 polyurethane Polymers 0.000 description 4
239000004814 polyurethane Substances 0.000 description 4
239000005060 rubber Substances 0.000 description 4
229910001220 stainless steel Inorganic materials 0.000 description 4
239000010935 stainless steel Substances 0.000 description 4
239000004696 Poly ether ether ketone Substances 0.000 description 3
210000003484 anatomy Anatomy 0.000 description 3
230000008901 benefit Effects 0.000 description 3
JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000007599 discharging Methods 0.000 description 3
238000012377 drug delivery Methods 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
239000003978 infusion fluid Substances 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
229920002530 polyetherether ketone Polymers 0.000 description 3
230000002485 urinary effect Effects 0.000 description 3
206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
108030001720 Bontoxilysin Proteins 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
239000004697 Polyetherimide Substances 0.000 description 2
239000004642 Polyimide Substances 0.000 description 2
208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
239000012867 bioactive agent Substances 0.000 description 2
230000000975 bioactive effect Effects 0.000 description 2
229940053031 botulinum toxin Drugs 0.000 description 2
239000013043 chemical agent Substances 0.000 description 2
239000002131 composite material Substances 0.000 description 2
230000006835 compression Effects 0.000 description 2
238000007906 compression Methods 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000013305 flexible fiber Substances 0.000 description 2
239000011521 glass Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
239000007769 metal material Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
229920001601 polyetherimide Polymers 0.000 description 2
229920001721 polyimide Polymers 0.000 description 2
208000017497 prostate disease Diseases 0.000 description 2
201000007094 prostatitis Diseases 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
239000010409 thin film Substances 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
ZZIZZTHXZRDOFM-UHFFFAOYSA-N 2-(2-ethoxyphenoxy)ethyl-[1-(4-methoxy-3-sulfamoylphenyl)propan-2-yl]azanium;chloride Chemical compound Cl.CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-UHFFFAOYSA-N 0.000 description 1
239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
241000723353 Chrysanthemum Species 0.000 description 1
235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
206010020853 Hypertonic bladder Diseases 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
229920000271 Kevlar® Polymers 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
206010061876 Obstruction Diseases 0.000 description 1
208000009722 Overactive Urinary Bladder Diseases 0.000 description 1
208000031481 Pathologic Constriction Diseases 0.000 description 1
244000208734 Pisonia aculeata Species 0.000 description 1
229920002614 Polyether block amide Polymers 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
229920004738 ULTEM® Polymers 0.000 description 1
229920004695 VICTREX™ PEEK Polymers 0.000 description 1
229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229960004607 alfuzosin Drugs 0.000 description 1
WNMJYKCGWZFFKR-UHFFFAOYSA-N alfuzosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(C)CCCNC(=O)C1CCCO1 WNMJYKCGWZFFKR-UHFFFAOYSA-N 0.000 description 1
239000002160 alpha blocker Substances 0.000 description 1
229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
230000002280 anti-androgenic effect Effects 0.000 description 1
239000000051 antiandrogen Substances 0.000 description 1
238000003491 array Methods 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000003124 biologic agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
229940089093 botox Drugs 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
230000008859 change Effects 0.000 description 1
239000004927 clay Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
229960001389 doxazosin Drugs 0.000 description 1
RUZYUOTYCVRMRZ-UHFFFAOYSA-N doxazosin Chemical compound C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 RUZYUOTYCVRMRZ-UHFFFAOYSA-N 0.000 description 1
229960004199 dutasteride Drugs 0.000 description 1
JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
229960004039 finasteride Drugs 0.000 description 1
DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
239000010439 graphite Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
230000005802 health problem Effects 0.000 description 1
230000003862 health status Effects 0.000 description 1
238000005286 illumination Methods 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
238000012966 insertion method Methods 0.000 description 1
239000004761 kevlar Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
208000020629 overactive bladder Diseases 0.000 description 1
230000035515 penetration Effects 0.000 description 1
210000002640 perineum Anatomy 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
229960001289 prazosin Drugs 0.000 description 1
IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
238000004886 process control Methods 0.000 description 1
208000021046 prostate intraepithelial neoplasia Diseases 0.000 description 1
201000004240 prostatic hypertrophy Diseases 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
239000011435 rock Substances 0.000 description 1
210000005070 sphincter Anatomy 0.000 description 1
230000036262 stenosis Effects 0.000 description 1
208000037804 stenosis Diseases 0.000 description 1
239000003351 stiffener Substances 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
229960003198 tamsulosin hydrochloride Drugs 0.000 description 1
229960001693 terazosin Drugs 0.000 description 1
VCKUSRYTPJJLNI-UHFFFAOYSA-N terazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1CCCO1 VCKUSRYTPJJLNI-UHFFFAOYSA-N 0.000 description 1
208000019206 urinary tract infection Diseases 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/0071—Multiple separate lumens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M2025/0079—Separate user-activated means, e.g. guidewires, guide tubes, balloon catheters or sheaths, for sealing off an orifice, e.g. a lumen or side holes, of a catheter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0087—Multiple injection needles protruding laterally from the distal tip
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M2025/0096—Catheter tip comprising a tool being laterally outward extensions or tools, e.g. hooks or fibres
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M25/0147—Tip steering devices with movable mechanical means, e.g. pull wires
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Pulmonology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Media Introduction/Drainage Providing Device (AREA)
Surgical Instruments (AREA)

JP2012118761A 2005-12-28 2012-05-24 組織へ流体を供与する装置、システムおよび関連方法 Withdrawn JP2012152636A (ja)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date
US75473005P	2005-12-28	2005-12-28
US60/754,730		2005-12-28
US86503506P	2006-11-09	2006-11-09
US60/865,035		2006-11-09
US86674106P	2006-11-21	2006-11-21
US60/866,741		2006-11-21

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2008548730A Division JP2009522010A (ja)	2005-12-28	2006-12-28	組織へ流体を供与する装置、システムおよび関連方法

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2014187573A Division JP6126056B2 (ja)	2005-12-28	2014-09-16	組織へ流体を供与する装置、システムおよび関連方法

Publications (1)

Publication Number	Publication Date
JP2012152636A true JP2012152636A (ja)	2012-08-16

Family

ID=38002210

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2012118761A Withdrawn JP2012152636A (ja)	2005-12-28	2012-05-24	組織へ流体を供与する装置、システムおよび関連方法
JP2014187573A Active JP6126056B2 (ja)	2005-12-28	2014-09-16	組織へ流体を供与する装置、システムおよび関連方法

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2014187573A Active JP6126056B2 (ja)	2005-12-28	2014-09-16	組織へ流体を供与する装置、システムおよび関連方法

Country Status (4)

Country	Link
EP (1)	EP1976585A2 (fr)
JP (2)	JP2012152636A (fr)
CA (1)	CA2633678C (fr)
WO (1)	WO2007079152A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7993264B2 (en)	2006-11-09	2011-08-09	Ams Research Corporation	Orientation adapter for injection tube in flexible endoscope
WO2009150594A1 (fr) *	2008-06-11	2009-12-17	Koninklijke Philips Electronics N.V.	Dispositif d’injection par microjet destiné à l’application locale sous-muqueuse de médicament
JP5701219B2 (ja)	2008-12-05	2015-04-15	エーエムエスリサーチコーポレイション	組織への流体の送達のための装置、システム、及び関連する方法
AU2009322967B2 (en) *	2008-12-05	2015-06-11	Ams Research Corporation	Devices, systems and methods for delivering fluid to tissue
US8366657B2 (en)	2008-12-05	2013-02-05	Ams Research Corporation	Needleless injection device components, systems, and methods
CA2744411C (fr)	2008-12-05	2018-03-27	Ams Research Corporation	Dispositifs, systemes et procedes d'apport de fluide a un tissu
US8852142B2 (en)	2008-12-16	2014-10-07	Ams Research Corporation	Needleless injection device components, systems, and methods
AU2009333892B2 (en)	2008-12-29	2015-09-24	Ams Research Corporation	Method and apparatus for compensating for injection media viscosity in a pressurized drug injection system
WO2011011372A2 (fr)	2009-07-20	2011-01-27	Ams Research Corporation	Composants, systèmes et procédés pour dispositif d'injection sans aiguille
WO2011011406A1 (fr) *	2009-07-20	2011-01-27	Ams Research Corporation	Dispositifs, systèmes et procédés d'administration d'un liquide dans un tissu
US9138535B2 (en)	2009-07-20	2015-09-22	Ams Research Corporation	High pressure injection catheter systems
WO2011011392A2 (fr) *	2009-07-20	2011-01-27	Ams Research Corporation	Procédés, systèmes, composants pour dispositif d'injection sans aiguille
WO2011035252A1 (fr)	2009-09-18	2011-03-24	Ams Research Corporation	Systèmes et procédés d'administration et de thérapie à base de cellules
WO2012038959A2 (fr) *	2010-09-21	2012-03-29	Israel Shamir Lebovitz	Aiguille multi-directionnelle
US8979797B2 (en)	2010-12-16	2015-03-17	Ams Research Corporation	High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
GB2484598B (en) *	2011-10-20	2014-02-12	Uropharma Ltd	Improvements in catheters
MX2012014854A (es) *	2012-12-17	2014-06-20	Luis Renee Gonzalez Lucano	Cateter para aplicacion intrauretral de sellantes de fibrina.
BR112015023408A2 (pt) *	2013-03-15	2017-07-18	Bard Inc C R	cateter de detecção de temperatura
US10960176B2 (en)	2014-12-19	2021-03-30	Hospital For Special Surgery	Multi-catheter infusion system and method thereof
EP3328464B1 (fr) *	2015-07-29	2022-05-11	Continale Medical Pte. Ltd.	Dispositif pour le traitement de l'incontinence urinaire d'effort (iue)
AU2019277668B2 (en) *	2018-06-01	2025-03-20	Presage Biosciences, Inc.	Low-profile multi-agent injection system and methods
WO2020182535A1 (fr) *	2019-03-08	2020-09-17	Bayer Oy	Tube de sonde utérine ayant un applicateur d'anesthésique
WO2021051158A1 (fr)	2019-09-16	2021-03-25	Ian S Middleton Pty Ltd	Cathéter urinaire et méthode de cathétérisme d'une vessie à l'aide d'un cathéter urétral à déviation active et d'un mécanisme de déviation
CA3143595A1 (fr) *	2019-11-20	2021-05-27	Ian S MIDDLETON	Catheter urinaire pouvant etre activement devie
EP4458399A1 (fr) *	2023-05-04	2024-11-06	FUJIFILM Corporation	Dispositif d'application d'un agent thérapeutique sous forme de fluide
US12377243B1 (en)	2024-10-01	2025-08-05	Uropharma Limited	Intermittent intravesical therapeutic administration system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0557021A (ja) *	1991-08-29	1993-03-09	Olympus Optical Co Ltd	穿刺針処置具
JP2000014663A (ja) *	1998-06-30	2000-01-18	Olympus Optical Co Ltd	前立腺肥大治療用装置
WO2001041656A1 (fr) *	1999-12-08	2001-06-14	Boston Scientific Limited	Procede et dispositif d'injection sans aiguille

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5007897A (en) *	1989-05-30	1991-04-16	Kalb Irvin M	Drug delivery catheter
US5336178A (en) *	1992-11-02	1994-08-09	Localmed, Inc.	Intravascular catheter with infusion array
US5588960A (en) *	1994-12-01	1996-12-31	Vidamed, Inc.	Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
US6280413B1 (en) *	1995-06-07	2001-08-28	Medtronic Ave, Inc.	Thrombolytic filtration and drug delivery catheter with a self-expanding portion
JP3732897B2 (ja) *	1996-07-09	2006-01-11	ペンタックス株式会社	内視鏡用注射具
US6058323A (en) *	1996-11-05	2000-05-02	Lemelson; Jerome	System and method for treating select tissue in a living being
US6302870B1 (en) *	1999-04-29	2001-10-16	Precision Vascular Systems, Inc.	Apparatus for injecting fluids into the walls of blood vessels, body cavities, and the like
US7458956B1 (en) *	1999-11-12	2008-12-02	Boston Scientific Scimed, Inc.	Apparatus for delivery of controlled doses of therapeutic drugs in endoluminal procedures
US6547767B1 (en) *	2000-11-14	2003-04-15	Advanced Cardiovascular Systems, Inc.	Syringe assembly for a catheter
US20100168656A1 (en) *	2005-09-28	2010-07-01	Anthony Lee	Apparatus and methods for treating urethral incontinence

2006
- 2006-12-28 CA CA2633678A patent/CA2633678C/fr not_active Expired - Fee Related
- 2006-12-28 EP EP06848253A patent/EP1976585A2/fr not_active Withdrawn
- 2006-12-28 WO PCT/US2006/049441 patent/WO2007079152A2/fr not_active Ceased
2012
- 2012-05-24 JP JP2012118761A patent/JP2012152636A/ja not_active Withdrawn
2014
- 2014-09-16 JP JP2014187573A patent/JP6126056B2/ja active Active

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0557021A (ja) *	1991-08-29	1993-03-09	Olympus Optical Co Ltd	穿刺針処置具
JP2000014663A (ja) *	1998-06-30	2000-01-18	Olympus Optical Co Ltd	前立腺肥大治療用装置
WO2001041656A1 (fr) *	1999-12-08	2001-06-14	Boston Scientific Limited	Procede et dispositif d'injection sans aiguille

Also Published As

Publication number	Publication date
CA2633678A1 (fr)	2007-07-12
EP1976585A2 (fr)	2008-10-08
AU2006332739A1 (en)	2007-07-12
JP2014231019A (ja)	2014-12-11
WO2007079152A3 (fr)	2007-12-06
CA2633678C (fr)	2013-08-13
WO2007079152A2 (fr)	2007-07-12
JP6126056B2 (ja)	2017-05-10

Legal Events

Date	Code	Title	Description
2012-05-25	A521	Written amendment	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120524
2012-05-25	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120524
2013-06-28	A977	Report on retrieval	Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130627
2013-07-03	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130702
2013-10-02	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131001
2013-10-07	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131004
2014-05-14	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140513
2014-09-17	A521	Written amendment	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140916
2014-10-04	A521	Written amendment	Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140917
2014-10-09	A911	Transfer of reconsideration by examiner before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20141008
2014-10-18	A761	Written withdrawal of application	Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20141017

Publication	Publication Date	Title
JP6126056B2 (ja)	2017-05-10	組織へ流体を供与する装置、システムおよび関連方法
US20090312696A1 (en)	2009-12-17	Devices, Systems, and Related Methods for Delivery of Fluid to Tissue
JP5701219B2 (ja)	2015-04-15	組織への流体の送達のための装置、システム、及び関連する方法
EP1833548B1 (fr)	2016-03-02	Systèmes de diffusion sans aiguille
US9675759B2 (en)	2017-06-13	Devices, systems, and methods for delivering fluid to tissue
US20150246178A1 (en)	2015-09-03	Devices, systems, and related methods for delivery of fluid to tissue
US9370646B2 (en)	2016-06-21	Devices, systems and methods for delivering fluid to tissue
US20150196717A1 (en)	2015-07-16	Needleless injection device components, systems, and methods
JP2009522010A (ja)	2009-06-11	組織へ流体を供与する装置、システムおよび関連方法
AU2010276343B2 (en)	2015-08-27	Devices, systems, and related methods for delivery of fluid to tissue
AU2015202124B2 (en)	2017-04-06	Devices, systems, and methods for delivering fluid to tissue
AU2015261555B2 (en)	2017-06-29	Devices, systems, and related methods for delivery of fluid to tissue
AU2015268621B2 (en)	2017-06-22	Devices, systems and methods for delivering fluid to tissue